The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Second interim analysis (IA2) results from a phase II trial of TAK-385, an oral GnRH antagonist, in prostate cancer patients (pts).
 
Fred Saad
Honoraria - Millennium
Consulting or Advisory Role - Millennium
Research Funding - Millennium (Inst)
 
James L. Bailen
Honoraria - Astellas Pharma; Auxilium; Bayer; Dendreon; Janssen; Sanofi
Consulting or Advisory Role - Astellas Pharma; Auxilium; Bayer; Dendreon; Janssen; Sanofi
Speakers' Bureau - Astellas Pharma; Auxilium; Bayer; Dendreon; Janssen; Sanofi
Research Funding - Astellas Pharma (Inst); Bayer; Dendreon (Inst); Janssen (Inst); Medivation (Inst); Millennium
Travel, Accommodations, Expenses - Astellas Pharma; Dendreon
 
Christopher Michael Pieczonka
Leadership - Associated Medical Professionals of New York
Stock and Other Ownership Interests - Trans Med
Honoraria - Astellas Pharma; Bayer; Dendreon; Janssen
Consulting or Advisory Role - Bayer; Janssen
Speakers' Bureau - Astellas Pharma; Bayer; Dendreon; Janssen
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Dendreon (Inst); Janssen (Inst)
 
Daniel R. Saltzstein
Research Funding - Millennium
 
Paul R. Sieber
Honoraria - Janssen
Speakers' Bureau - Amgen; Astellas Pharma; Ferring; Janssen; Medivation
Research Funding - Astellas Pharma; Bavarian Nordic; Janssen; Medivation; Millennium
 
David B. Maclean
Employment - Millennium
 
Hongliang Shi
Employment - Millennium
 
Helene M. Faessel
Employment - Millennium
 
Neal D. Shore
Consulting or Advisory Role - Astellas Pharma; Bayer; Dendreon; Ferring; Janssen; Millennium; Sanofi